UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 51

Sortiert nach

PDB20 Estimated Prevalence of Hypoparathyroidism in the United States Using a Large Claims Database and Disease Severity From Primary Market Research

Value in health, 2012-06, Vol.15 (4), p.A174-A174

2012

Volltextzugriff (PDF)

La paltusotine, agoniste oral non peptidique spécifique du récepteur de la somatostatine de type 2 (SST2), administré une fois par jour, est associé à une tolérance et à une efficacité à long terme chez les patients atteints d’acromégalie

Annales d'endocrinologie, 2022-10, Vol.83 (5), p.331-332

2022

Volltextzugriff (PDF)

587 Results from the phase 3, double-blind, vehicle-controlled ESSENCE trial of the topical investigational drug SD-101 in epidermolysis bullosa

Journal of investigative dermatology, 2018-05, Vol.138 (5), p.S100-S100

2018

Volltextzugriff (PDF)

585 Natural history of wound closure and other clinical endpoints in epidermolysis bullosa: Lessons from a 90-day multicenter trial

Journal of investigative dermatology, 2018-05, Vol.138 (5), p.S99-S99

2018

Volltextzugriff (PDF)

701 Investigation of the absorption of allantoin in vitro skin models to support wound healing

Journal of investigative dermatology, 2017-05, Vol.137 (5), p.S120-S120

2017

Volltextzugriff (PDF)

696 Characteristics of patients (pts) with epidermolysis bullosa (EB) in the phase 3 ESSENCE study of SD-101

Journal of investigative dermatology, 2017-05, Vol.137 (5), p.S120-S120

2017

Volltextzugriff (PDF)

PRECLINICAL APPROACHES AND EARLY CLINICAL RESULTS: O.22First-in-human study of ATB200/AT2221 in patients with Pompe disease: 24-month functional assessment results from the ATB200-02 trial

Neuromuscular disorders : NMD, 2019-10, Vol.29, p.S122-S122

2019

Volltextzugriff (PDF)

PRECLINICAL APPROACHES AND EARLY CLINICAL RESULTS

Neuromuscular disorders : NMD, 2019-10, Vol.29, p.S122

2019

Volltextzugriff (PDF)

Phorbol myristate acetate stimulates ATP-dependent calcium transport by the plasma membrane of neutrophils

The Journal of clinical investigation, 1984-03, Vol.73 (3), p.878-883

1984

Volltextzugriff (PDF)

Single-drug versus combination empirical therapy for gram-negative bacillary infections in febrile cancer patients with and without granulocytopenia

Antimicrobial Agents and Chemotherapy, 1984-12, Vol.26 (6), p.870-875

1984

Volltextzugriff (PDF)

Clinical evaluation of teicoplanin for therapy of severe infections caused by gram-positive bacteria

Antimicrobial Agents and Chemotherapy, 1986-01, Vol.29 (1), p.52-57

1986

Volltextzugriff (PDF)

Antistaphylococcal activity of rifampin with other antibiotics

The Journal of infectious diseases, 1981-10, Vol.144 (4), p.365

1981

Volltextzugriff (PDF)

Comparison of pharmacokinetics and bactericidal activity of teicoplanin and vancomycin

Journal of antimicrobial chemotherapy, 1986-10, Vol.18 (4), p.513-520

1986

Volltextzugriff (PDF)

Clinical experience with perindopril in African-American hypertensive patients: a large United States community trial

American journal of hypertension, 2004-02, Vol.17 (2), p.134-138

2004

Volltextzugriff (PDF)

Polypropylene production and colorectal cancer: a review of the epidemiological evidence

Occupational medicine (Oxford), 1995-04, Vol.45 (2), p.69-74

1995

Volltextzugriff (PDF)

Serum bactericidal activity of ceftazidime and cefoperazone alone or in combination with amikacin against Pseudomonas aeruginosa and Klebsiella pneumoniae

Antimicrobial Agents and Chemotherapy, 1983-03, Vol.23 (3), p.435-439

1983

Volltextzugriff (PDF)

Treatment of gram-negative bacillary septicemia with cefoperazone

European Journal of Clinical Microbiology, 1983-12, Vol.2 (6), p.554-558

1983

Volltextzugriff (PDF)

Bactericidal activity of ciprofloxacin in serum and urine against Escherichia coli, Pseudomonas aeruginosa, Klebsiella pneumoniae, Staphylococcus aureus and Streptococcus faecalis

Journal of antimicrobial chemotherapy, 1985-01, Vol.16 (3), p.341-347

1985

Volltextzugriff (PDF)

Serum bactericidal activity and killing rate for volunteers receiving imipenem, imipenem plus amikacin, and ceftazidime plus amikacin against Pseudomonas aeruginosa

Antimicrobial Agents and Chemotherapy, 1986-07, Vol.30 (1), p.122-126

1986

Volltextzugriff (PDF)

Comparative in vitro activities of temocillin and cefazolin against Klebsiella pneumoniae

Antimicrobial Agents and Chemotherapy, 1982-08, Vol.22 (2), p.330-331

1982

Volltextzugriff (PDF)

Safe biotechnology. III: Safety precautions for handling microorganisms of different risk classes

Applied microbiology and biotechnology, 1989-06, Vol.30 (6), p.541-552

1989

Volltextzugriff (PDF)

Adenosine triphosphate-dependent calcium pump in the plasma membrane of guinea pig and human neutrophils

The Journal of clinical investigation, 1984, Vol.73 (1), p.107-115

1984

Volltextzugriff (PDF)

Serum Bactericidal Activity of Moxalactam and Cefotaxime With and Without Tobramycin Against Pseudomonas aeruginosa and Staphylococcus aureus

Antimicrobial Agents and Chemotherapy, 1981-10, Vol.20 (4), p.539-541

1981

Volltextzugriff (PDF)

Empirical antimicrobial therapy with Timentin plus amikacin in febrile granulocytopenic cancer patients

Journal of antimicrobial chemotherapy, 1986-05, Vol.17 Suppl C, p.195-201

1986

Volltextzugriff (PDF)

Moxalactam treatment of anaerobic infections in cancer patients

Antimicrobial Agents and Chemotherapy, 1982-10, Vol.22 (4), p.604-610

1982

Volltextzugriff (PDF)

1 – 25 von 51

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(51)
Mit Volltextzugriff
(47)

Publikationsform

Artikel
(51)

Sprache

Erscheinungsjahr

n.n

Thema

Humans
(26)
Life Sciences & Biomedicine
(26)
Science & Technology
(26)
Female
(16)
Male
(16)
Biological And Medical Sciences
(15)
Microbiology
(13)
Adult
(12)
Infectious Diseases
(11)
Medical Sciences
(11)
Pharmacology & Pharmacy
(11)
Middle Aged
(10)
Antibacterial Agents
(9)
Antibiotics. Antiinfectious Agents. Antiparasitic Agents
(9)
Pharmacology. Drug Treatments
(9)
Microbial Sensitivity Tests
(8)
Pseudomonas Aeruginosa - Drug Effects
(8)
Aged
(7)
Klebsiella Pneumoniae - Drug Effects
(7)
Pseudomonas Aeruginosa
(7)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

PDB20 Estimated Prevalence of Hypoparathyroidism in the United States Using a Large Claims Database and Disease Severity From Primary Market Research

La paltusotine, agoniste oral non peptidique spécifique du récepteur de la somatostatine de type 2 (SST2), administré une fois par jour, est associé à une tolérance et à une efficacité à long terme chez les patients atteints d’acromégalie

587 Results from the phase 3, double-blind, vehicle-controlled ESSENCE trial of the topical investigational drug SD-101 in epidermolysis bullosa

585 Natural history of wound closure and other clinical endpoints in epidermolysis bullosa: Lessons from a 90-day multicenter trial

701 Investigation of the absorption of allantoin in vitro skin models to support wound healing

696 Characteristics of patients (pts) with epidermolysis bullosa (EB) in the phase 3 ESSENCE study of SD-101

PRECLINICAL APPROACHES AND EARLY CLINICAL RESULTS: O.22First-in-human study of ATB200/AT2221 in patients with Pompe disease: 24-month functional assessment results from the ATB200-02 trial

PRECLINICAL APPROACHES AND EARLY CLINICAL RESULTS

Phorbol myristate acetate stimulates ATP-dependent calcium transport by the plasma membrane of neutrophils

Single-drug versus combination empirical therapy for gram-negative bacillary infections in febrile cancer patients with and without granulocytopenia

Clinical evaluation of teicoplanin for therapy of severe infections caused by gram-positive bacteria

Antistaphylococcal activity of rifampin with other antibiotics

Comparison of pharmacokinetics and bactericidal activity of teicoplanin and vancomycin

Clinical experience with perindopril in African-American hypertensive patients: a large United States community trial

Polypropylene production and colorectal cancer: a review of the epidemiological evidence

Serum bactericidal activity of ceftazidime and cefoperazone alone or in combination with amikacin against Pseudomonas aeruginosa and Klebsiella pneumoniae

Treatment of gram-negative bacillary septicemia with cefoperazone

Bactericidal activity of ciprofloxacin in serum and urine against Escherichia coli, Pseudomonas aeruginosa, Klebsiella pneumoniae, Staphylococcus aureus and Streptococcus faecalis

Serum bactericidal activity and killing rate for volunteers receiving imipenem, imipenem plus amikacin, and ceftazidime plus amikacin against Pseudomonas aeruginosa

Comparative in vitro activities of temocillin and cefazolin against Klebsiella pneumoniae

Safe biotechnology. III: Safety precautions for handling microorganisms of different risk classes

Adenosine triphosphate-dependent calcium pump in the plasma membrane of guinea pig and human neutrophils

Serum Bactericidal Activity of Moxalactam and Cefotaxime With and Without Tobramycin Against Pseudomonas aeruginosa and Staphylococcus aureus

Empirical antimicrobial therapy with Timentin plus amikacin in febrile granulocytopenic cancer patients

Moxalactam treatment of anaerobic infections in cancer patients

Suchergebnisse filtern